Michael Hahn

Michael Hahn

Auto-generated profile, based on publicly available information

Michael Hahn

Institut für Osteologie und Biomechanik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KTKorzinskas Tadas
Korzinskas Tadas
Ole JungOle Jung
Ole Jung
Ralf SmeetsRalf Smeets
Ralf Smeets
Sanja StojanovićSanja Stojanović
Sanja Stojanović
Stevo J. NajmanStevo J. Najman
Stevo J. Najman
Mike BarbeckMike Barbeck
Mike Barbeck
The use of non-resorbable polytetrafluoroethylene (PTFE) membranes is indicated for the treatment of large, non-self-containing bone defects, or multi-walled defects in the case of vertical augmentations. However, less is known about the molecular basis of the foreign body response to PTFE membranes. In the present study, the inflammatory tissue responses to a novel high-density PTFE (dPTFE) barrier membrane have preclinically been evaluated using the subcutaneous implantation model in BALB/c mice by means of histopathological and histomorphometrical analysis methods and immunohistochemical detection of M1- and M2-macrophages. A collagen membrane was used as the control material. The results of the present study demonstrate that the tissue response to the dPTFE membrane involves inflammatory macrophages, but comparable cell numbers were also detected in the implant beds of the control collagen membrane, which is known to be biocompatible. Although these data indicate that the analyzed dPTFE membrane is not fully bioinert, but its biocompatibility is comparable to collagen-based membranes. Based on its optimal biocompatibility, the novel dPTFE barrier membrane may optimally support bone healing within the context of guided bone regeneration (GBR).


Verified
Journal Article
Open access
PDF file
APAnnica Pröhl
Annica Pröhl
MBMilijana Batinic
Milijana Batinic
SASaid Alkildani
Said Alkildani
MHMichael Hahn
Michael Hahn
MSMilena Radenković Stošić
Milena Radenković Stošić
Mike BarbeckMike Barbeck
Mike Barbeck
The present in vivo study analyses both the inflammatory tissue reactions and the bone healing capacity of a newly developed bone substitute material (BSM) based on xenogeneic bone substitute granules combined with hyaluronate (HY) as a water-binding molecule. The results of the hyaluronate containing bone substitute material (BSM) were compared to a control xenogeneic BSM of the same chemical composition and a sham operation group up to 16 weeks post implantationem. A major focus of the study was to analyze the residual hyaluronate and its effects on the material-dependent healing behavior and the inflammatory tissue responses. The study included 63 male Wistar rats using the calvaria implantation model for 2, 8, and 16 weeks post implantationem. Established and Good Laboratory Practice (GLP)-conforming histological, histopathological, and histomorphometrical analysis methods were conducted. The results showed that the new hyaluronate containing BSM was gradually integrated within newly formed bone up to the end of the study that ended in a condition of complete bone defect healing. Thereby, no differences to the healing capacity of the control BSM were found. However, the bone formation in both groups was continuously significantly higher compared to the sham operation group. Additionally, no differences in the (inflammatory) tissue response that was analyzed via qualitative and (semi-) quantitative methods were found. Interestingly, no differences were found between the numbers of pro- and anti-inflammatory macrophages between the three study groups over the entire course of the study. No signs of the HY as a water-binding part of the BSM were histologically detectable at any of the study time points, altogether the results of the present study show that HY allows for an optimal material-associated bone tissue healing comparable to the control xenogeneic BSM. The added HY seems to be degraded within a very short time period of less than 2 weeks so that the remaining BSM granules allow for a gradual osteoconductive bone regeneration. Additionally, no differences between the inflammatory tissue reactions in both material groups and the sham operation group were found. Thus, the new hyaluronate containing xenogeneic BSM and also the control BSM have been shown to be fully biocompatible without any differences regarding bone regeneration.

24 November 2012 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
MDMarija Djuric
Marija Djuric
SZSlavisa Zagorac
Slavisa Zagorac
PMPetar Milovanović
Petar Milovanović
DDDanijela Djonic
Danijela Djonic
SNSlobodan Nikolić
Slobodan Nikolić
RMRobert Percy Marshall
Robert Percy Marshall

26 November 2021 in Materials Today Bio
Verified
Journal Article
Open access
FSFelix N. Schmidt
Felix N. Schmidt
MHMichael Hahn
Michael Hahn
KSKilian E. Stockhausen
Kilian E. Stockhausen
TRTim Rolvien
Tim Rolvien
CSConstantin Schmidt
Constantin Schmidt
BBBjörn Busse
Björn Busse
Doses of irradiation above 25 ​kGy are known to cause irreversible mechanical decay in bone tissue. However, the impact of irradiation doses absorbed in a clinical setting on the mechanical properties of bone remains unclear. In daily clinical practice and research, patients and specimens are exposed to irradiation due to diagnostic imaging tools, with doses ranging from milligray to Gray. The aim of this study was to investigate the influence of irradiation at these doses ranges on the mechanical performance of bone independent of inter-individual bone quality indices.

30 May 2016 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
MHMichael Hahn
Michael Hahn
BBBjörn Busse
Björn Busse
MPMathias Procop
Mathias Procop
JZJozef Zustin
Jozef Zustin
MAMichael Amling
Michael Amling
AKAlexander Katzer
Alexander Katzer